Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15740 | 695 | 32.2 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
267 | 3 | PALLIATIVE CARE//END OF LIFE CARE//PSYCHO-ONCOLOGY | 44147 |
228 | 2 | PSYCHO-ONCOLOGY//SHARED DECISION MAKING//SUPPORTIVE CARE IN CANCER | 20371 |
15740 | 1 | PRODUCTIVITY COSTS//FINANCIAL TOXICITY//FUTURE COSTS | 695 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRODUCTIVITY COSTS | authKW | 440547 | 3% | 53% | 19 |
2 | FINANCIAL TOXICITY | authKW | 197702 | 1% | 75% | 6 |
3 | FUTURE COSTS | authKW | 156906 | 1% | 71% | 5 |
4 | COST OF ILLNESS | authKW | 135503 | 8% | 6% | 56 |
5 | HLTH SERV ECON BRANCH | address | 131045 | 3% | 16% | 19 |
6 | FINANCIAL BURDEN | authKW | 109811 | 2% | 17% | 15 |
7 | OUT OF POCKET COSTS | authKW | 103695 | 2% | 20% | 12 |
8 | FRICTION COST APPROACH | authKW | 98851 | 0% | 75% | 3 |
9 | CARDIOVASC METABOL SERV | address | 87869 | 0% | 100% | 2 |
10 | DEGROOTE BUSINESS MGD 210 | address | 87869 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Health Policy & Services | 18867 | 27% | 0% | 189 |
2 | Health Care Sciences & Services | 15343 | 32% | 0% | 222 |
3 | Oncology | 4575 | 42% | 0% | 294 |
4 | Economics | 864 | 13% | 0% | 89 |
5 | Public, Environmental & Occupational Health | 723 | 14% | 0% | 99 |
6 | Medical Informatics | 275 | 3% | 0% | 18 |
7 | Social Sciences, Biomedical | 206 | 2% | 0% | 17 |
8 | Medicine, General & Internal | 168 | 9% | 0% | 61 |
9 | Rehabilitation | 111 | 3% | 0% | 21 |
10 | Nursing | 109 | 3% | 0% | 18 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HLTH SERV ECON BRANCH | 131045 | 3% | 16% | 19 |
2 | CARDIOVASC METABOL SERV | 87869 | 0% | 100% | 2 |
3 | DEGROOTE BUSINESS MGD 210 | 87869 | 0% | 100% | 2 |
4 | KINGS HLTH PARTNERS CANC | 49422 | 0% | 38% | 3 |
5 | CANC POLICY | 49416 | 1% | 19% | 6 |
6 | ABORAT CANC CARE GRP 3CRG | 43934 | 0% | 100% | 1 |
7 | ABT EPIDEMOL SOZIALMED GESUNDHEITSSYST FOR | 43934 | 0% | 100% | 1 |
8 | ADULT CHILD HLTH OUTCOMES DELIVERY SCI | 43934 | 0% | 100% | 1 |
9 | ADVOCACY PROGRAMMES | 43934 | 0% | 100% | 1 |
10 | AGR ECON DEN HAAG | 43934 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF HEALTH ECONOMICS | 21022 | 3% | 3% | 18 |
2 | PHARMACOECONOMICS | 13473 | 4% | 1% | 26 |
3 | HEALTH ECONOMICS | 7581 | 3% | 1% | 18 |
4 | EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 6988 | 1% | 2% | 9 |
5 | VALUE IN HEALTH | 6331 | 2% | 1% | 15 |
6 | MEDICAL CARE | 5239 | 4% | 0% | 25 |
7 | AMERICAN JOURNAL OF MANAGED CARE | 5207 | 3% | 1% | 18 |
8 | HEALTH AFFAIRS | 4477 | 3% | 0% | 22 |
9 | CLINICAL ONCOLOGY-US | 4392 | 0% | 10% | 1 |
10 | ONCOLOGIST | 3874 | 2% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRODUCTIVITY COSTS | 440547 | 3% | 53% | 19 | Search PRODUCTIVITY+COSTS | Search PRODUCTIVITY+COSTS |
2 | FINANCIAL TOXICITY | 197702 | 1% | 75% | 6 | Search FINANCIAL+TOXICITY | Search FINANCIAL+TOXICITY |
3 | FUTURE COSTS | 156906 | 1% | 71% | 5 | Search FUTURE+COSTS | Search FUTURE+COSTS |
4 | COST OF ILLNESS | 135503 | 8% | 6% | 56 | Search COST+OF+ILLNESS | Search COST+OF+ILLNESS |
5 | FINANCIAL BURDEN | 109811 | 2% | 17% | 15 | Search FINANCIAL+BURDEN | Search FINANCIAL+BURDEN |
6 | OUT OF POCKET COSTS | 103695 | 2% | 20% | 12 | Search OUT+OF+POCKET+COSTS | Search OUT+OF+POCKET+COSTS |
7 | FRICTION COST APPROACH | 98851 | 0% | 75% | 3 | Search FRICTION+COST+APPROACH | Search FRICTION+COST+APPROACH |
8 | FRICTION PERIOD | 87869 | 0% | 100% | 2 | Search FRICTION+PERIOD | Search FRICTION+PERIOD |
9 | LONG TERM COST | 87869 | 0% | 100% | 2 | Search LONG+TERM+COST | Search LONG+TERM+COST |
10 | SURVIVAL CONSUMPTION COSTS | 87869 | 0% | 100% | 2 | Search SURVIVAL+CONSUMPTION+COSTS | Search SURVIVAL+CONSUMPTION+COSTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HANLY, P , PEARCE, A , SHARP, L , (2014) THE COST OF PREMATURE CANCER-RELATED MORTALITY: A REVIEW AND ASSESSMENT OF THE EVIDENCE.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. VOL. 14. ISSUE 3. P. 355-377 | 33 | 67% | 3 |
2 | WHITNEY, RL , BELL, JF , REED, SC , LASH, R , BOLD, RJ , KIM, KK , DAVIS, A , COPENHAVER, D , JOSEPH, JG , (2016) PREDICTORS OF FINANCIAL DIFFICULTIES AND WORK MODIFICATIONS AMONG CANCER SURVIVORS IN THE UNITED STATES.JOURNAL OF CANCER SURVIVORSHIP. VOL. 10. ISSUE 2. P. 241 -250 | 20 | 87% | 0 |
3 | YABROFF, KR , DOWLING, EC , GUY, GP , BANEGAS, MP , DAVIDOFF, A , HAN, XS , VIRGO, KS , MCNEEL, TS , CHAWLA, N , BLANCH-HARTIGAN, D , ET AL (2016) FINANCIAL HARDSHIP ASSOCIATED WITH CANCER IN THE UNITED STATES: FINDINGS FROM A POPULATION-BASED SAMPLE OF ADULT CANCER SURVIVORS.JOURNAL OF CLINICAL ONCOLOGY. VOL. 34. ISSUE 3. P. 259 -U125 | 22 | 61% | 4 |
4 | YABROFF, KR , LUND, J , KEPKA, D , MARIOTTO, A , (2011) ECONOMIC BURDEN OF CANCER IN THE UNITED STATES: ESTIMATES, PROJECTIONS, AND FUTURE RESEARCH.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 20. ISSUE 10. P. 2006 -2014 | 26 | 52% | 55 |
5 | KROL, M , BROUWER, W , (2014) HOW TO ESTIMATE PRODUCTIVITY COSTS IN ECONOMIC EVALUATIONS.PHARMACOECONOMICS. VOL. 32. ISSUE 4. P. 335-344 | 22 | 51% | 22 |
6 | BANEGAS, MP , GUY, GP , DE MOOR, JS , EKWUEME, DU , VIRGO, KS , KENT, EE , NUTT, S , ZHENG, ZY , RECHIS, R , YABROFF, KR , (2016) FOR WORKING-AGE CANCER SURVIVORS, MEDICAL DEBT AND BANKRUPTCY CREATE FINANCIAL HARDSHIPS.HEALTH AFFAIRS. VOL. 35. ISSUE 1. P. 54 -61 | 19 | 59% | 1 |
7 | KROL, M , BROUWER, W , RUTTEN, F , (2013) PRODUCTIVITY COSTS IN ECONOMIC EVALUATIONS: PAST, PRESENT, FUTURE.PHARMACOECONOMICS. VOL. 31. ISSUE 7. P. 537-549 | 25 | 44% | 30 |
8 | MARIOTTO, AB , YABROFF, KR , SHAO, YW , FEUER, EJ , BROWN, ML , (2011) PROJECTIONS OF THE COST OF CANCER CARE IN THE UNITED STATES: 2010-2020.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 103. ISSUE 2. P. 117 -128 | 9 | 64% | 551 |
9 | ZHENG, ZY , YABROFF, KR , GUY, GP , HAN, XS , LI, CY , BANEGAS, MP , EKWUEME, DU , JEMAL, A , (2016) ANNUAL MEDICAL EXPENDITURE AND PRODUCTIVITY LOSS AMONG COLORECTAL, FEMALE BREAST, AND PROSTATE CANCER SURVIVORS IN THE UNITED STATES.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 108. ISSUE 5. P. - | 19 | 56% | 1 |
10 | YABROFF, KR , WARREN, JL , BROWN, ML , (2007) COSTS OF CANCER CARE IN THE USA: A DESCRIPTIVE REVIEW.NATURE CLINICAL PRACTICE ONCOLOGY. VOL. 4. ISSUE 11. P. 643-656 | 29 | 45% | 37 |
Classes with closest relation at Level 1 |